INTELLIPHARMA WKN: A2N5Y4 ISIN: CA4581733090 Kürzel: I4AA Forum: Aktien Thema: Hauptdiskussion

Gailooooooooooooooooo!! 😀✌️👊

Hab gerade geschaut brauche nur 33 Cent. 😅

Donnerwetter! Brauch 40 Cent dann erst plus minus null. 🙄

Im Moment nur 🚀💥

Gibt es heute noch einen Rücksetzer oder geht es weiter hoch

Intellipharmaceutics Announces FDA Advisory Committee Meeting for Aximris XR(TM) (Oxycodone Hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain https://ir.intellipharmaceutics.com/press-releases/detail/216/intellipharmaceutics-announces-fda-advisory-committee

Oh was denn hier los

Ein Update zu Rexista wäre mir lieber.... Intellipharmaceutics Announces an Update in the Purdue Litigation https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/intellipharmaceutics-announces-purdue-litigation-120000553.html

Intellipharmaceutics Signs a Second Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. TORONTO, ON / ACCESSWIRE / September 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, announced today that it has entered into a license and commercial supply agreement with Tris Pharma, Inc. ("Tris"), by which the Company has granted Tris an exclusive license to market, sell and distribute in the United States, Desvenlafaxine Succinate ER in the 50 and 100 mg strengths (the "licensed products") approved for sale in the U.S. market by the U.S. Food and Drug Administration ("FDA"). Several other generic versions of the licensed products are currently available in the market. There can be no assurance that the licensed products will be successfully commercialized or produce significant revenue, or any revenue for the Company. http://app.quotemedia.com/quotetools/newsItem.htm?webmasterId=102683&storyId=4677035111355161

Selbst das verpufft heute: Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. https://finance.yahoo.com/news/intellipharmaceutics-signs-exclusive-license-commercial-191500762.html

https://ir.intellipharmaceutics.com/press-releases/detail/207/intellipharmaceutics-international-inc-announces-update-on

Intellipharmaceutics Announces Second Quarter 2019 Results https://finance.yahoo.com/news/intellipharmaceutics-announces-second-quarter-2019-210000222.html?.tsrc=rss

CRL ausgestellt am 25. September 2017. NDA erneut eingereicht mit neuem PDUFA-Datum vom 28. August 2019.

Erst wenn ich im Gewinn bin.

+50% und niemand schreibt ganz aufgeregt im forum? :D

Kann mir vielleicht jemand verraten was hier los ist?Danke